Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8551 |
High Similarity |
NPD3027 |
Phase 3 |
0.8273 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8112 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8112 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8112 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7885 |
Intermediate Similarity |
NPD37 |
Approved |
0.7847 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7817 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7762 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7736 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7736 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7736 |
Intermediate Similarity |
NPD4965 |
Approved |
0.773 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7708 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7704 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7682 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7619 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7606 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7606 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD228 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7535 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7465 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7455 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7431 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7407 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3022 |
Approved |
0.74 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7391 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7361 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7324 |
Intermediate Similarity |
NPD4626 |
Approved |
0.732 |
Intermediate Similarity |
NPD5763 |
Approved |
0.732 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.729 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6100 |
Approved |
0.725 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7215 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7215 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7215 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7211 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7195 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1283 |
Approved |
0.717 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7151 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD1653 |
Approved |
0.707 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7051 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.702 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7018 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7013 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6986 |
Remote Similarity |
NPD1281 |
Approved |
0.6986 |
Remote Similarity |
NPD1611 |
Approved |
0.6982 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD8651 |
Approved |
0.6954 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6951 |
Remote Similarity |
NPD5090 |
Approved |
0.6951 |
Remote Similarity |
NPD5089 |
Approved |
0.695 |
Remote Similarity |
NPD1398 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD1607 |
Approved |
0.6944 |
Remote Similarity |
NPD3091 |
Approved |
0.6936 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD8054 |
Approved |
0.6932 |
Remote Similarity |
NPD8053 |
Approved |
0.6928 |
Remote Similarity |
NPD4140 |
Approved |
0.6928 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6928 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD2438 |
Suspended |
0.6923 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6918 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6908 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD2489 |
Approved |
0.6901 |
Remote Similarity |
NPD27 |
Approved |
0.6899 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6894 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD1669 |
Approved |
0.689 |
Remote Similarity |
NPD4678 |
Approved |
0.689 |
Remote Similarity |
NPD4675 |
Approved |
0.6889 |
Remote Similarity |
NPD940 |
Approved |
0.6889 |
Remote Similarity |
NPD846 |
Approved |
0.6884 |
Remote Similarity |
NPD2342 |
Discontinued |
0.6883 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6879 |
Remote Similarity |
NPD7054 |
Approved |
0.6875 |
Remote Similarity |
NPD4577 |
Approved |
0.6875 |
Remote Similarity |
NPD7313 |
Approved |
0.6875 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD7310 |
Approved |
0.6875 |
Remote Similarity |
NPD7312 |
Approved |
0.6875 |
Remote Similarity |
NPD4578 |
Approved |
0.6875 |
Remote Similarity |
NPD7311 |
Approved |
0.6872 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD5929 |
Approved |
0.6867 |
Remote Similarity |
NPD7819 |
Suspended |
0.6855 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD3750 |
Approved |
0.6855 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6854 |
Remote Similarity |
NPD4663 |
Approved |
0.6853 |
Remote Similarity |
NPD6671 |
Approved |
0.6849 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6849 |
Remote Similarity |
NPD5126 |
Approved |
0.6848 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD7831 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD7833 |
Phase 2 |
0.6842 |
Remote Similarity |
NPD2970 |
Approved |
0.6842 |
Remote Similarity |
NPD2969 |
Approved |
0.6839 |
Remote Similarity |
NPD6353 |
Approved |
0.6839 |
Remote Similarity |
NPD7472 |
Approved |
0.6839 |
Remote Similarity |
NPD2157 |
Approved |
0.6836 |
Remote Similarity |
NPD7309 |
Approved |
0.6832 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6832 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6824 |
Remote Similarity |
NPD2230 |
Approved |
0.6824 |
Remote Similarity |
NPD2233 |
Approved |
0.6824 |
Remote Similarity |
NPD2232 |
Approved |
0.6818 |
Remote Similarity |
NPD1240 |
Approved |
0.6816 |
Remote Similarity |
NPD7906 |
Approved |
0.6815 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6813 |
Remote Similarity |
NPD2677 |
Approved |
0.681 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD4536 |
Approved |
0.6795 |
Remote Similarity |
NPD4538 |
Approved |
0.6792 |
Remote Similarity |
NPD3060 |
Approved |
0.6788 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6784 |
Remote Similarity |
NPD3051 |
Approved |
0.6781 |
Remote Similarity |
NPD1357 |
Approved |
0.6774 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6774 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6774 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6765 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6757 |
Remote Similarity |
NPD1091 |
Approved |
0.6753 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6752 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6752 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6752 |
Remote Similarity |
NPD5588 |
Approved |
0.6752 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.675
|
Remote Similarity |
NPD7003 |
Approved |